Want to see AU:FCG full AI Analyst Report?
Top Page
Freedom Care Group Holdings Limited
(Sydney:FCG)
Select Model
Select Model
Rating:41Neutral
Price Target:
AU$0.04
▼(-12.50% Downside)
Action:N/A
Date:09/23/26
The score is primarily constrained by severe deterioration in financial performance (revenue collapse, large losses, and negative operating/free cash flow). Technicals provide little support with weak momentum and no clear trend versus key moving averages. Valuation is also unfavorable due to negative earnings (negative P/E) and no dividend yield data.
Positive Factors
Manageable leverage
Low and stable debt levels provide some financial flexibility compared with a highly leveraged structure. This can reduce interest and refinancing pressure, preserve capacity to address operational challenges, and leave more room for future investment if the business stabilizes.
Negative Factors
Severe revenue contraction
The multiyear collapse in revenue shows a major loss of operating scale rather than a normal quarterly fluctuation. Such a reduced revenue base makes fixed costs harder to absorb, weakens earnings capacity, and raises the execution challenge for rebuilding sustainable growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
Low and stable debt levels provide some financial flexibility compared with a highly leveraged structure. This can reduce interest and refinancing pressure, preserve capacity to address operational challenges, and leave more room for future investment if the business stabilizes.
Read all positive factors
Freedom Care Group Holdings Limited (FCG) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$4.01M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)-10.34
Revenue Growth-97.98%
EPS Growth91.33%
CountryAU
Employees29
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding108,317,245
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)5.02
Price to Sales (P/S)12.57
P/FCF Ratio-60.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Freedom Care Group Holdings Limited Business Overview & Revenue Model
Company Description
Headquartered in Villawood, Australia, Freedom Care Group Holdings Ltd. delivers services under the National Disability Insurance Scheme (NDIS). Established by Jamal Sabsabi, the company provides essential allied health and direct care to individu...
Freedom Care Group Holdings Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
60
Neutral
Cash Flow
22
Negative
| Breakdown | Jun 2026 | Jun 2024 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 319.00K | 7.25M | 18.97M | 23.62M | 11.68M |
| Gross Profit | 47.00K | 7.25M | 18.97M | 7.89M | 10.39M |
| EBITDA | -59.00K | -3.66M | 1.98M | 4.11M | -71.93K |
| Net Income | -347.00K | -4.00M | 891.00K | 2.66M | -144.76K |
Balance Sheet | |||||
| Total Assets | 1.45M | 1.47M | 9.86M | 6.29M | 1.64M |
| Cash, Cash Equivalents and Short-Term Investments | 407.00K | 473.00K | 4.14M | 3.65M | 924.16K |
| Total Debt | 200.00K | 200.00K | 2.47M | 964.00K | 131.59K |
| Total Liabilities | 653.00K | 328.00K | 4.43M | 2.74M | 1.21M |
| Stockholders Equity | 798.00K | 1.15M | 5.32M | 3.29M | 433.33K |
Cash Flow | |||||
| Free Cash Flow | -66.00K | -4.10M | 2.44M | 3.05M | 540.06K |
| Operating Cash Flow | -66.00K | -4.08M | 2.61M | 3.26M | 575.88K |
| Investing Cash Flow | 0.00 | 261.00K | -1.24M | -205.00K | -35.81K |
| Financing Cash Flow | 0.00 | 148.00K | -876.00K | -699.00K | -15.14K |
Freedom Care Group Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | AU$9.29B | 15.28 | 7.20% | 5.75% | 14.40% | 15.11% | |
58 Neutral | AU$12.71B | 40.67 | 6.58% | 1.65% | 4.36% | 4799.64% | |
53 Neutral | AU$1.35B | 24.16 | -264.68% | 4.13% | 16.55% | 13.42% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | AU$275.95M | -0.66 | -114.08% | 35.60% | 2.16% | 21.05% | |
50 Neutral | AU$223.47M | -14.06 | -5.34% | 2.79% | 1.84% | -178.23% | |
41 Neutral | AU$4.01M | -10.28 | -41.70% | ― | -97.98% | 91.33% |
* Healthcare Sector Average
AU:FCG
Freedom Care Group Holdings Limited
0.04
0.00
0.00%
AU:HLS
Healius Limited
0.38
-0.37
-48.99%
AU:RHC
Ramsay Health Care
55.31
24.33
78.54%
AU:PGC
Paragon Care Limited
0.14
-0.15
-52.63%
AU:REG
Regis Healthcare Ltd.
4.46
-1.41
-24.01%
AU:SHL
Sonic Healthcare Limited
18.79
-1.37
-6.78%
Freedom Care Group Holdings Limited Corporate Events
Freedom Care Group to Benefit from Sale of Koala Disability Care Business
Sep 18, 2026
Freedom Care Group Holdings Limited has announced that Koala Disability Care Pty Ltd, in which its subsidiary holds a 29% stake, has agreed to sell its Tuggerah-based disability care and registered NDIS provider business to Ello Care Pty Ltd for a...
Freedom Care Group AGM Reveals Shareholder Opposition to Remuneration Report
Sep 2, 2026
Freedom Care Group Holdings Limited has released the voting results from its 2025 Annual General Meeting held on 2 September 2026, detailing shareholder decisions on key governance resolutions. The announcement, authorised by Company Secretary Way...
Freedom Care Group Files ASX Governance Statement for 2026
Aug 31, 2026
Freedom Care Group Holdings Limited has lodged its corporate governance statement and accompanying Appendix 4G with the ASX for the year ended 30 June 2026, confirming compliance with key governance principles. The disclosures outline board and ma...
Freedom Care Group Posts Sharply Reduced Loss Amid Subsidiary Liquidations
Aug 31, 2026
Freedom Care Group Holdings Limited reported a steep contraction in activity for the year to 30 June 2026, with revenue from ordinary activities plunging 98% to $319,000 and the net loss narrowing sharply to $347,000 from $3.999 million a year ear...
Freedom Care Group Sets 2026 AGM to Approve 2025 Results and Board Re-election
Jul 31, 2026
Freedom Care Group Holdings Limited has called its Annual General Meeting for 2 September 2026 in Sydney, setting 31 August 2026 as the shareholder record date for voting eligibility. The AGM will review the company’s financial statements fo...
Freedom Care Group Faces ASX Deadlines Over Long-Term Suspension
Jul 10, 2026
Freedom Care Group Holdings Limited has been identified by ASX as a long‑term suspended entity, having its securities suspended from trading for more than three months. The company has not yet lodged its third quarter activities and cashflow...
Freedom Care Group Updates Registered Office to New NSW Address
Jul 1, 2026
Freedom Care Group Holdings Limited has officially changed its registered office address to 31 Edward Street, Sylvania, NSW 2224, effective 1 July 2026, in line with ASX Listing Rule 3.14 requirements. The administrative move, approved by the boar...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.